Jasme Lee, MS

Research Biostatistician
Epidemiology & Biostatistics
Directory
Epidemiology
Biostatistics
Health Outcomes
Computational Oncology
Administrative Resources
Career Opportunities
Educational Opportunities
Departmental Newsletter

Jasme Lee, MS

Research Biostatistician
Share
Share
Jasme Lee

Email

[email protected]

Education

North Carolina State University

Current Research Interest 

Jasme primarily collaborates with clinicians in the Anesthesiology and Critical Care service with Dr. Kay See Tan, in Exercise Oncology service with Dr. Chaya Moskowitz, and in Bone Marrow Transplant (BMT) with Dr. Sean Devlin. She is part of the Biostatistics Team supporting the planning and data quality assurance of an institution-wide effort to build a comprehensive research database from augmenting genomic data with curated clinical data. She also works with Drs Ronglai Shen and Kathy Panageas on Immunotherapy research: currently the team is building an automated gating pipeline for flow cytometry analysis to alleviate the bottleneck experienced in the traditionally manual process. 

Publications

  1. Imber, B. S., Chau, K. W., Lee, J., Lee, J., Casey, D. L., Yang, J. C., … & Yahalom, J. (2021). Excellent Response to Very Low Dose Radiation (4Gy) For Indolent B-cell Lymphomas: Is 4Gy Suitable for Curable Patients?. Blood Advances.
  2. Dahi, P. B., Lee, J., Devlin, S. M., Ruiz, J., Maloy, M., Rondon-Clavo, C., … & Giralt, S. A. (2021). Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma. Blood Advances, 5(12), 2608-2618.
  3. Leap, K. E., Chen, G. H., Lee, J., Tan, K. S., & Malhotra, V. (2021). Identifying Prevalence of and Risk Factors for Abnormal Urine Drug Tests in Cancer Pain Patients. Journal of Pain and Symptom Management, 62(2), 355-363.
  4. Scott, J. M., Lee, J., Herndon, J. E., Michalski, M. G., Lee, C. P., O’Brien, K. A., … & Jones, L. W. (2023). Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial. European Heart Journal, ehad085.
  5. Ecker, B. L., Lee, J., Saadat, L. V., Aparicio, T., Buisman, F. E., Balachandran, V. P., … & D’Angelica, M. I. (2022). Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: A retrospective study and meta-analysis. The Lancet Oncology, 23(10), 1332-1342.